Century Therapeutics Statistics
Total Valuation
IPSC has a market cap or net worth of $48.15 million. The enterprise value is -$64.30 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IPSC has 86.16 million shares outstanding. The number of shares has increased by 40.42% in one year.
| Current Share Class | 86.16M |
| Shares Outstanding | 86.16M |
| Shares Change (YoY) | +40.42% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 4.47% |
| Owned by Institutions (%) | 31.91% |
| Float | 45.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| Forward PS | 7.07 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.70, with a Debt / Equity ratio of 0.22.
| Current Ratio | 11.70 |
| Quick Ratio | 11.45 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.49% and return on invested capital (ROIC) is -7.17%.
| Return on Equity (ROE) | -10.49% |
| Return on Assets (ROA) | -5.59% |
| Return on Invested Capital (ROIC) | -7.17% |
| Return on Capital Employed (ROCE) | -9.86% |
| Revenue Per Employee | $765,987 |
| Profits Per Employee | -$146,293 |
| Employee Count | 150 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $1.79 million in taxes.
| Income Tax | 1.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.07% in the last 52 weeks. The beta is 1.81, so IPSC's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -83.07% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 53.52 |
| Average Volume (20 Days) | 710,782 |
Short Selling Information
The latest short interest is 2.75 million, so 3.19% of the outstanding shares have been sold short.
| Short Interest | 2.75M |
| Short Previous Month | 3.49M |
| Short % of Shares Out | 3.19% |
| Short % of Float | 6.10% |
| Short Ratio (days to cover) | 4.05 |
Income Statement
In the last 12 months, IPSC had revenue of $114.90 million and -$21.94 million in losses. Loss per share was -$0.26.
| Revenue | 114.90M |
| Gross Profit | 4.50M |
| Operating Income | -29.68M |
| Pretax Income | -131.64M |
| Net Income | -21.94M |
| EBITDA | -16.38M |
| EBIT | -29.68M |
| Loss Per Share | -$0.26 |
Full Income StatementBalance Sheet
The company has $165.12 million in cash and $52.68 million in debt, giving a net cash position of $112.45 million or $1.31 per share.
| Cash & Cash Equivalents | 165.12M |
| Total Debt | 52.68M |
| Net Cash | 112.45M |
| Net Cash Per Share | $1.31 |
| Equity (Book Value) | 240.44M |
| Book Value Per Share | 2.79 |
| Working Capital | 155.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$114.51 million and capital expenditures -$90,000, giving a free cash flow of -$114.60 million.
| Operating Cash Flow | -114.51M |
| Capital Expenditures | -90,000 |
| Free Cash Flow | -114.60M |
| FCF Per Share | -$1.33 |
Full Cash Flow StatementMargins
Gross margin is 3.91%, with operating and profit margins of -25.83% and -19.10%.
| Gross Margin | 3.91% |
| Operating Margin | -25.83% |
| Pretax Margin | -17.54% |
| Profit Margin | -19.10% |
| EBITDA Margin | -14.26% |
| EBIT Margin | -25.83% |
| FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.42% |
| Shareholder Yield | -40.42% |
| Earnings Yield | -45.58% |
| FCF Yield | -238.03% |
Analyst Forecast
The average price target for IPSC is $3.33, which is 495.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.33 |
| Price Target Difference | 495.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -34.99% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IPSC has an Altman Z-Score of -1.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.3 |
| Piotroski F-Score | 2 |